Magnevist and Indocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnevist (gadopentetate dimeglumine) and Indocin (indomethacin). Common drug interactions include arthralgia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Magnevist and Indocin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Magnevist?

Magnevist has active ingredients of gadopentetate dimeglumine. eHealthMe is studying from 10,524 Magnevist users. Check the latest studies of Magnevist.

What is Indocin?

Indocin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 4,559 Indocin users. Check the latest studies of Indocin.

On Jul, 17, 2026

19 people who take Magnevist and Indocin together, and have interactions are studied.

Magnevist and Indocin drug interactions.

What are the common drug interactions of Magnevist and Indocin, by gender? *:

female:

Arthralgia (joint pain)
Asthenia (weakness)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pruritus (severe itching of the skin)
Skin burning sensation

male:

Emotional distress
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Scar
Skin fibrosis (fibrous tissue formation on skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin plaque (red, scaly patches to appear on the skin)
Skin tightness
Skin ulcer
Rash pruritic (redness with itching)

What are the common drug interactions of Magnevist and Indocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Asthenia (weakness)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pruritus (severe itching of the skin)
Skin burning sensation

40-49:

n/a

50-59:

n/a

60+:

Emotional distress
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Scar
Skin fibrosis (fibrous tissue formation on skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin plaque (red, scaly patches to appear on the skin)
Skin tightness
Skin ulcer
Rash pruritic (redness with itching)

What are the existing conditions these people have? *

Carotid Artery Occlusion (artery blockage): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Magnevist and Indocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously